Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC29A1 | Q99808 | 4/20 | 0.47 |
| ▸ | APP | P05067 | 3/20 | 0.33 |
| ▸ | BCHE | P06276 | 3/20 | 0.33 |
| ▸ | ACHE | P22303 | 3/20 | 0.33 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.33 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | MERTK | Q12866 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16094312 | 0.89 | SLC29A1 (0.51) | SLC29A1APPBCHEACHETLR7 | |
| Hydrochloric Acid SCHEMBL17494536 | 0.88 | SLC29A1 (0.50) | SLC29A1APPBCHEACHETLR7 | |
| SCHEMBL20164443 | 0.85 | SLC29A1 (0.66) | SLC29A1APPBCHEACHETLR7 | |
| Hydrochloric Acid SCHEMBL20164696 | 0.83 | SLC29A1 (0.64) | SLC29A1APPBCHEACHETLR7 | |
| SCHEMBL16094829 | 0.82 | SLC29A1 (0.71) | SLC29A1APPBCHEACHECYP1A2 | |
| SCHEMBL20164523 | 0.82 | SLC29A1 (0.62) | SLC29A1TLR7MERTK | |
| Hydrochloric Acid SCHEMBL20164421 | 0.81 | SLC29A1 (0.60) | SLC29A1TLR7MERTK | |
| SCHEMBL18826169 | 0.80 | SLC29A1 (0.44) | SLC29A1APPBCHEACHETLR7 | |
| SCHEMBL16093975 | 0.80 | SLC29A1 (0.44) | SLC29A1APPBCHEACHETLR7 | |
| SCHEMBL16094775 | 0.80 | SLC29A1 (0.48) | SLC29A1APPBCHEACHETLR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3316890-B1 | NOVEL BREATHING CONTROL MODULATING COMPOUNDS, AND METHODS OF MAKING AND USING SAME | NEURAD LTD (IL) | 2023-09-06 | — | — | EP | disclosed |
| US-10294228-B2 | Breathing control modulating compounds, and methods of making and using same | NEURAD LTD. (IL) | 2019-05-21 | — | — | US | disclosed |
| US-20180141953-A1 | Novel Breathing Control Modulating Compounds, and Methods of Making and Using Same | NEURAD LTD. (IL) | 2018-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180141953-A1 | Novel Breathing Control Modulating Compounds, and Methods of Making and Using Same | MTNR1B, CHRM3, PER2 | SLC29A1 4472/4885APP 2716/4885BCHE 156/4885 |
| US-10294228-B2 | Breathing control modulating compounds, and methods of making and using same | MTNR1B, PDE3A, CHRM3 | SLC29A1 4518/4885APP 2394/4885BCHE 98/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.